Drug Rehab Programs New Brunswick Call 732-709-4471 for Alcohol Rehab, Detox NJ
Drug Rehab Programs New Brunswick Call 732-709-4471 For Alcohol Rehab, Detox NJ – www.delrayrecoverycenter.com Drug Rehab Programs New Brunswick Call 732-709-4471 For Alcohol Rehab, Detox NJ. Delray Recovery Center is located in beautiful Delray Beach, Florida. Our professional treatment services include a 5 phase step-down model, aftercare, relapse treatment, psychological services, dual diagnosis and family intervention for long term physical, physiological, behavioral, social and spiritual recovery no matter if you or your loved one is suffering from drug, alcohol or prescription drug addiNJion and any other substance abuse. We offer drug rehab New Brunswick, alcohol rehab New Brunswick, drug detox New Brunswick, drug rehab centers New Brunswick, alcohol rehab centers New Brunswick, drug rehabilitation New Brunswick, drug rehab programs New Brunswick, drug treatment New Brunswick, alcohol treatment New Brunswick, residential drug rehab. Talk with one of our experienced, kind and caring counselors today: 732-709-4471
Antares Pharma Announces Submission of New Drug Application for OTREXUP
Filed under: drug treatment programs nj
EWING, N.J.–(BUSINESS WIRE)–Dec 17, 2012 – Antares Pharma, Inc. (NASDAQ: ATRS) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for OTREXUP™, a combination product for the delivery of …
Read more on PharmaLive (press release) (subscription)
Eisai Inc. Divests US Rights for GLIADEL® Wafer (polifeprosan 20 with …
Filed under: drug treatment programs nj
WOODCLIFF LAKE, N.J. and ATLANTA, Dec. … "The transition of U.S. rights for Gliadel to Arbor will ensure that patients who may benefit from treatment with Gliadel will continue to have access to it, while also enabling Eisai to reallocate funding and …
Read more on The Herald | HeraldOnline.com
Enzon to Review Potential Sale After Icahn Wants Talk
Filed under: drug treatment programs nj
Lazard Ltd. (LAZ) was hired to help explore the possibility of a sale, Piscataway, New Jersey-based Enzon said today in a statement. To conserve cash, Enzon suspended development and testing of its androgen receptor treatment. Icahn said Nov. 28 he had …
Read more on Bloomberg